The Commission’s upcoming pharmaceutical strategy has set its sights on big ambitions, wanting access to medicines for a greater number of people and tackling regional inequalities, while bolstering Europe’s supply. But how can it thread the line between putting a lid on the growing costs of medicines, for example by promoting transparency on drug prices and cooperation between member countries, while still enticing drugmakers to sell and manufacture their drugs in Europe?
This event is for POLITICO PRO subscribers. If you are not a pro subscriber but interested in attending, please email pro@politico.eu.